Enter the MedStartr Launchathon — Aug 1–Oct 6 in NYC
< Back to companies
AssetWatch

AssetWatch

Predictive maintenance for pharma uptime

Dublin, Ohio, United States

OtherSeries C

AssetWatch is a company providing end-to-end condition monitoring and AI-driven predictive maintenance solutions.

Hero image for AssetWatch
Note, this image was autogenerated by Syggy based on what we know about the company. It is not an official company publication.
Get Involved in AssetWatch
Claim This Profile →

How We Help

Problem Statement

Unplanned downtime and sub-optimal operations in industrial and manufacturing sectors.

Core Technology

Wireless sensors, AI-driven analytics, Centralized platform for real-time monitoring

Key Differentiators

End-to-end condition monitoring; AI-driven predictive maintenance solutions; Wireless sensors; AI-driven analytics; Expert insights; Prevents unplanned downtime

Target Customers

Global manufacturers across industrial sectors including pharmaceutical & healthcare, plastics, pulp & paper, water & wastewater, chemicals, food & beverage, forestry & building materials, metals & processing, mining & aggregates, and textiles & apparel.

Product Stage

GA

Company Info

Business Model
B2B SaaS
Founded
2014
Total Funding
167,500,000
Website
assetwatch.com

Categories

Other

Disease Areas

Technologies

Wireless SensorsCommunication HubsAI-driven AnalyticsPredictive MaintenanceRemote Condition MonitoringAIIoTPredictive AnalyticsAsset Tracking

Clinical & IP

🔬

Clinical Validation

Deployed across 20+ pharmaceutical and healthcare manufacturing facilities. Documented case studies: fan component replacement ($58k saved), agitator bearing replacement ($150k saved), motor replacement ($250k saved). Operates within FDA-regulated pharma manufacturing environments.

MedStartr Index Score

?
59

What do you think of AssetWatch?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Get Involved in AssetWatch